Intended for healthcare professionals

CCBYNC Open access
Corrections

Anticholinergic drugs and risk of dementia: case-control study

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6213 (Published 31 October 2019) Cite this as: BMJ 2019;367:l6213

An error occurred in this paper by Richardson and colleagues (BMJ 2018;361:k1315, doi:10.1136/bmj.k1315, published 25 April 2018). The corresponding author’s email address should be kathryn.richardson@uea.ac.uk. The paper and PDF will be updated in due course.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.